Dow Jones

38,686.32

0.00%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

ADRX

Andrx (ADRX)

Andrx

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ADRX

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
31/10/2006	15:02	PR Newswire (US)	Watson Receives FTC Clearance for Andrx Acquisition	NASDAQ:ADRX	Andrx
18/10/2006	08:05	PR Newswire (US)	Watson Certifies Substantial Compliance With FTC Second Request	NASDAQ:ADRX	Andrx
13/09/2006	06:30	Business Wire	Andrx Certifies to the Satisfaction of Certain Conditions to Closing Acquisition by Watson	NASDAQ:ADRX	Andrx
08/08/2006	17:06	Business Wire	Andrx Corporation Reports Financial Results for 2006 Second Quarter	NASDAQ:ADRX	Andrx
01/08/2006	07:00	Business Wire	Andrx to Issue Financial Results for 2006 Second Quarter	NASDAQ:ADRX	Andrx
04/05/2006	16:28	Business Wire	Andrx Corporation Reports Financial Results for 2006 First Quarter	NASDAQ:ADRX	Andrx
03/05/2006	06:00	PR Newswire (US)	Watson Pharmaceuticals and Andrx Corporation Receive FTC Second Request	NASDAQ:ADRX	Andrx
26/04/2006	11:16	Business Wire	Andrx to Issue Financial Results for 2006 First Quarter and Host Conference Call	NASDAQ:ADRX	Andrx
04/04/2006	06:58	Business Wire	Andrx Announces Filing of NDA by Takeda for ACTOS and Extended-Release Metformin Combination Product	NASDAQ:ADRX	Andrx
16/03/2006	15:09	Business Wire	Andrx Corporation Reports Financial Results for 2005 Fourth Quarter and Full Year	NASDAQ:ADRX	Andrx
13/03/2006	13:58	Business Wire	Andrx to Issue Financial Results for 2005 Fourth Quarter and Full Year and Host Conference Call	NASDAQ:ADRX	Andrx
13/03/2006	06:00	PR Newswire (US)	Watson to Acquire Andrx For $1.9 Billion, Creating the Third Largest Specialty Pharmaceutical Company In the U.S.	NASDAQ:ADRX	Andrx
13/03/2006	06:00	Business Wire	Andrx to Be Acquired by Watson for $25.00 Per Share; Total Transaction Valued at Approximately $1.9 Billion	NASDAQ:ADRX	Andrx
02/02/2006	13:18	Business Wire	Andrx to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference	NASDAQ:ADRX	Andrx
23/01/2006	11:20	Business Wire	Andrx Announces Commercialization Agreement with InvaGen	NASDAQ:ADRX	Andrx
18/01/2006	07:00	Business Wire	Andrx Granted Summary Judgment for Generic Toprol-XL	NASDAQ:ADRX	Andrx
11/11/2005	07:00	Business Wire	Andrx Comments On Clarithromycin ER Preliminary Injunction	NASDAQ:ADRX	Andrx
07/11/2005	16:09	Business Wire	Andrx Corporation Reports 2005 Third Quarter Results	NASDAQ:ADRX	Andrx
04/11/2005	14:37	Business Wire	Andrx to Present at CIBC World Markets Healthcare Conference	NASDAQ:ADRX	Andrx
02/11/2005	13:20	Business Wire	Stull, Stull & Brody Announces Class Action on Behalf of Shareholders of Andrx Corp.	NASDAQ:ADRX	Andrx
02/11/2005	09:16	Business Wire	Andrx to Issue 2005 Third Quarter Financial Results and Host Conference Call	NASDAQ:ADRX	Andrx
26/10/2005	14:36	Business Wire	Andrx Resumes Full Operations Post-Hurricane Wilma	NASDAQ:ADRX	Andrx
19/10/2005	09:48	Business Wire	Andrx Announces ANDA Filing for Cardizem LA	NASDAQ:ADRX	Andrx
18/10/2005	18:12	PR Newswire (US)	Federman & Sherwood Announces That a Securities Class Action Lawsuit Was Filed Against Andrx Corporation	NASDAQ:ADRX	Andrx
23/09/2005	07:47	Business Wire	Andrx to Present at UBS Global Life Sciences Conference	NASDAQ:ADRX	Andrx
20/09/2005	13:00	Business Wire	Andrx Announces Change in Chief Financial Officer	NASDAQ:ADRX	Andrx
16/09/2005	08:01	Business Wire	Andrx Appoints Robert I. Goldfarb Senior Vice President, General Counsel and Secretary	NASDAQ:ADRX	Andrx
09/09/2005	08:05	Business Wire	Andrx to Present at Bear Stearns Annual Healthcare Conference	NASDAQ:ADRX	Andrx
06/09/2005	08:31	Business Wire	Andrx Reports on FDA Developments	NASDAQ:ADRX	Andrx
18/07/2005	15:15	Business Wire	Andrx to Issue 2005 Second Quarter Financial Results and Host Conference Call	NASDAQ:ADRX	Andrx